VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $781,000 | +38.0% | 33,600 | -5.5% | 0.12% | +33.3% |
| Q1 2018 | $566,000 | -26.7% | 35,555 | -4.0% | 0.09% | -23.7% |
| Q4 2017 | $772,000 | +45.7% | 37,055 | 0.0% | 0.11% | +37.3% |
| Q3 2017 | $530,000 | -17.4% | 37,055 | 0.0% | 0.08% | -21.0% |
| Q2 2017 | $642,000 | +57.0% | 37,055 | 0.0% | 0.10% | +50.0% |
| Q1 2017 | $409,000 | -24.0% | 37,055 | 0.0% | 0.07% | -23.1% |
| Q4 2016 | $538,000 | -19.2% | 37,055 | +36.5% | 0.09% | -24.8% |
| Q3 2016 | $666,000 | +45.1% | 27,155 | +18.5% | 0.12% | +37.5% |
| Q2 2016 | $459,000 | -23.6% | 22,910 | 0.0% | 0.09% | -22.1% |
| Q1 2016 | $601,000 | -74.2% | 22,910 | 0.0% | 0.11% | -75.8% |
| Q4 2015 | $2,327,000 | -42.9% | 22,910 | 0.0% | 0.47% | -45.2% |
| Q3 2015 | $4,074,000 | -41.8% | 22,910 | -27.3% | 0.85% | -37.3% |
| Q2 2015 | $6,999,000 | +12.2% | 31,510 | -0.3% | 1.36% | +10.8% |
| Q1 2015 | $6,236,000 | +37.6% | 31,610 | 0.0% | 1.23% | +44.4% |
| Q4 2014 | $4,532,000 | +15.0% | 31,610 | +5.0% | 0.85% | +14.1% |
| Q3 2014 | $3,942,000 | +3.6% | 30,110 | 0.0% | 0.74% | +5.2% |
| Q2 2014 | $3,806,000 | -17.6% | 30,110 | -14.2% | 0.71% | -21.8% |
| Q1 2014 | $4,620,000 | +12.3% | 35,110 | 0.0% | 0.90% | +9.2% |
| Q4 2013 | $4,114,000 | +12.2% | 35,110 | 0.0% | 0.83% | +6.0% |
| Q3 2013 | $3,666,000 | +15.7% | 35,110 | 0.0% | 0.78% | +10.2% |
| Q2 2013 | $3,168,000 | – | 35,110 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |